Yalei Wen
-
- Cancer Cells and Metastasis 4
- Cancer-related Molecular Pathways 2
-
- Ubiquitin and proteasome pathways 8
- Histone Deacetylase Inhibitors Research 4
- Protein Degradation and Inhibitors 4
- Epigenetics and DNA Methylation 3
- Metabolism, Diabetes, and Cancer 2
-
- Hippo pathway signaling and YAP/TAZ 2
- Co-authors
- Tongzheng LiuCaishi ZhangMei LiYing‐Jie ZhuYuchen GaoHui TangXiao YangHongyan Yang
- Partner nations
- ChinaThailandUnited States
In The Last Decade
Yalei Wen
16 papers receiving 281 citations
Peers
Comparison fields: 5 of 71
- Oncology 97
- Cancer Research 40
- Molecular Biology 170
- Immunology 39
- Hematology 17
Countries citing papers authored by Yalei Wen
This map shows the geographic impact of Yalei Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yalei Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yalei Wen more than expected).
Fields of papers citing papers by Yalei Wen
This network shows the impact of papers produced by Yalei Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yalei Wen. The network helps show where Yalei Wen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yalei Wen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 10 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 31 | |
| 11 | 2023 | 7 | |
| 12 | 2023 | 9 | |
| 13 | 2022 | 109 | |
| 14 | 2022 | 73 | |
| 15 | 2021 | 9 | |
| 16 | 2020 | 10 |
About Yalei Wen
Yalei Wen is a scholar working on Oncology, Molecular Biology and Molecular Medicine, having authored 16 papers that have together received 283 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (8 papers), Histone Deacetylase Inhibitors Research (4 papers), Protein Degradation and Inhibitors (4 papers), Cancer Cells and Metastasis (4 papers), Epigenetics and DNA Methylation (3 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Cancer-related Molecular Pathways (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Oncology (97 citations), Cancer Research (40 citations) and Molecular Biology (170 citations). Yalei Wen has collaborated with scholars based in China, Thailand and United States. Frequent co-authors include Tongzheng Liu, Caishi Zhang, Mei Li, Ying‐Jie Zhu, Yuchen Gao, Hui Tang, Xiao Yang, Hongyan Yang, Xiaoyun Lu and Chaofan Wang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.